NASDAQ: INDP - Indaptus Therapeutics, Inc.

Lønnsomhet i seks måneder: -46.56%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Indaptus Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as chronic hepatitis B virus and human immunodeficiency virus infection, which is in Phase 2 clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc.

flere detaljer
is headquartered in New York, New York.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2015-08-04
ISIN US45339J1051
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://indaptusrx.com
Цена ао 0.8174
Prisendring per dag: +6.78% (0.7857)
Prisendring per uke: +4.87% (0.8)
Prisendring per måned: -8.8% (0.92)
Prisendring over 3 måneder: -17.75% (1.02)
Prisendring over seks måneder: -46.56% (1.5699)
Prisendring per år: -59.86% (2.09)
Prisendring over 3 år: -80.84% (4.38)
Prisendring over 5 år: +188.61% (0.2907)
Prisendring over 10 år: 0% (0.839)
Prisendring siden begynnelsen av året: +0.3709% (0.8359)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 1.32 9
P/E 0 0
EV/EBITDA -0.1694 0
Total: 3.63

Effektivitet

Navn Betydning Karakter
ROA, % -103.35 0
ROE, % -127.71 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0107 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % -51.97 0
Lønnsomhet EPS, % -98.37 0
Total: 0
Flere detaljer

Institusjoner Volum Dele, %
Vanguard Group Inc 256265 3
Investment House, LLC 102437 1.2
Geode Capital Management, LLC 54767 0.64
Strategy Asset Managers Llc 45336 0.53
Pine Valley Investments Ltd Liability Co 44240 0.52
Renaissance Technologies, LLC 29400 0.34
Vivaldi Capital Management Lp 24000 0.28
State Street Corporation 19473 0.23
Citadel Advisors Llc 16518 0.19
Tower Research Capital LLC (TRC) 4696 0.05



Veileder Stillingstittel Betaling Fødselsår
Mr. Jeffrey A. Meckler CEO & Director 867.03k 1967 (58 år)
Mr. Walt Addison Linscott Esq. Chief Operating Officer 716.35k 1961 (64 år)
Dr. Michael J. Newman Ph.D. Founder, Chief Scientific Officer & Director 659.99k 1956 (69 år)
Mr. Nir Sassi CFO, Secretary & Treasurer 378.47k 1976 (49 år)
Dr. Roger J. Waltzman M.B.A., M.D. Chief Medical Officer N/A 1968 (57 år)

Adresse: United States, New York. NY, Three Columbus Circle - åpne i Google maps, åpne Yandex-kart
Nettsted: https://indaptusrx.com